描述基于药品护理的药剂师干预和在第三级护理中心的脆弱性评分工具
Justine Falanga-Duchesneau1, Gabrielle Plante2, Julie Racicot3
1, PharmD, was, at the time of this study, a Resident Pharmacist with the Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Quebec. She is now a Pharmacist with the same institution.
The Canadian journal of hospital pharmacy
|November 13, 2025
概括
一个新的患者优先级工具可以帮助药剂师识别需要护理的弱势患者. 较高的脆弱性得分与更多的干预相关,尽管关键护理的响应时间需要改进.
科学领域:
- 药房实践 在药房实践.
- 医疗保健服务研究 医疗服务研究
- 患者安全 患者安全
背景情况:
- 北克大学心脏病和肺病研究所重组了药房实践,以改善药物护理的提供.
- 开发了一种新的患者优先级工具,根据药物和文献定义的因素分配脆弱性得分.
- 该工具将患者分为强制性 (1天内) 或优先 (1-3天) 护理组.
研究的目的:
- 根据新的优先级工具的评分,评估医院住院患者的药剂师干预措施.
- 评估患者脆弱性得分与提供的药物护理之间的关系.
- 分析不同患者风险水平的干预措施的及时性.
主要方法:
- 一项前性研究包括2023年5月10日至19日期间至少住院48小时的304名患者.
- 优先级工具应用于所有患者,并以前性记录干预措施.
- 数据分析包括频率分析,皮尔森相关性和百分比计算.
主要成果:
- 药剂师对194名患者进行了1023次干预;干预频率随着患者脆弱性得分的增加而增加.
- 具有强制性 (n=64) 和优先 (n=186) 指定的患者得到了及时的护理,平均反应时间分别为1.25和1.57天.
- 图表审查是最常见的活动 (44.3%),其次是处方药 (11.2%).
结论:
- 患者优先级工具有效地将更高的脆弱性得分与药剂师干预的增加联系起来.
- 虽然优先护理响应时间符合建议,但强制性护理响应时间需要优化.
- 该工具有助于优化药物护理提供,并识别需要及时干预的患者.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:15Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
01:29Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
141
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
141
01:24Dosage Regimen: Individualization
160
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
160
01:28Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248